Prospective Evaluation of Ustekinumab Dose Intensification in Inflammatory Bowel Diseases.
Many people on ustekinumab who lose response wonder whether increasing dosing frequency helps. This prospective study suggests that empiric intensification to every 4 or 6 weeks raised drug levels and was linked with...